SCN5A Variant K480E
Summary of observed carriers, functional annotations, and structural context for SCN5A K480E. Data combine curated literature, international cohorts, and gnomAD observations.
Estimated LQT3 penetrance
3%
0/10 effective observations
Estimated BrS1 penetrance
9%
0/10 effective observations
Total carriers
0
0 BrS1 · 0 LQT3 · 0 unaffected
Variant features alone are equivalent to phenotyping 0 individuals for Brugada syndrome and 0 individuals for LQT3.
In silico predictors
PROVEAN | PolyPhen-2 | BLAST-PSSM | REVEL | Penetrance Density BrS (%) | Penetrance Density LQT3 (%) |
---|---|---|---|---|---|
NA | NA | NA | 0.652 | 5 | 0 |
PROVEAN scores below -2 suggest deleterious impact. REVEL scores above 0.5–0.75 are often interpreted as likely pathogenic. PolyPhen-2 scores above 0.85 are typically pathogenic. Penetrance density summarises neighbouring residue risk (Kroncke et al. 2019).
Reported carrier data
Source | Year | Carriers | Unaffected | LQT3 | BrS1 | Other | Other Disease |
---|---|---|---|---|---|---|---|
Literature, cohort, and gnomAD | – | 0 | 0 | 0 | 0 | – | |
Variant features alone | – | 15 | 15 | 0 | 0 | – | – |
Totals may differ from individual publications due to duplicate patients removed during curation.
Nearby variants
Neighbouring residues within 15 Ångström provide structural context. Variants listed in the right-most column have been observed clinically or in gnomAD.
Neighbour residue | Distance (Å) | Observed variants |
---|---|---|
465 | 15 | p.P465LfsX5, |
466 | 14 | L466F, |
467 | 14 | |
468 | 13 | P468L, |
469 | 13 | V469I, |
470 | 12 | N470K, |
471 | 11 | |
472 | 11 | |
473 | 10 | E473X, |
474 | 9 | R474K, R474G, |
475 | 8 | R475K, R475S, |
476 | 8 | |
477 | 7 | c.1428_1431delCAAG, |
478 | 5 | |
479 | 4 | |
480 | 0 | K480N, |
481 | 4 | R481W, R481Q, |
482 | 5 | M482I, |
483 | 7 | |
484 | 8 | |
485 | 8 | |
486 | 9 | T486S, T486A, |
487 | 10 | |
488 | 11 | |
489 | 11 | |
490 | 12 | G490A, G490E, |
491 | 13 | E491G, |
492 | 13 | |
493 | 14 | R493K, |
494 | 14 | |
495 | 15 |